{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:31:28Z","timestamp":1790364688388,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012028","name":"Trombosestichting Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtha.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:33:22Z","timestamp":1759995202000},"page":"955-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-8674","authenticated-orcid":false,"given":"Eva K.","family":"Kempers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk J.","family":"Adriaansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Beinema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina J.","family":"ten Cate-Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.A.","family":"Dronkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchior C.","family":"Nierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Schindhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynke M.","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.M.","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Pisters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.W.","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-4871","authenticated-orcid":false,"given":"Marieke J.H.A.","family":"Kruip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.09.010_bib1","series-title":"Eur Heart J","first-page":"ehaf194","article-title":"2025 ESC\/EACTS Guidelines for the management of valvular heart disease","author":"Praz","year":"2025"},{"key":"10.1016\/j.jtha.2025.09.010_bib2","first-page":"e72","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.09.010_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.09.010_bib4","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.09.010_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve","volume":"2","author":"Wang","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jtha.2025.09.010_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.09.010_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC working group on thrombosis\u2014task force on anticoagulants in heart disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archinternmed.2009.176","article-title":"Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients","volume":"169","author":"Torn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.09.010_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1538-7836.2007.02874.x","article-title":"Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants","volume":"6","author":"van Leeuwen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.thromres.2015.10.044","article-title":"INR variability and outcomes in patients with mechanical heart valve prosthesis","volume":"136","author":"Labaf","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.010_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/heartjnl-2016-309585","article-title":"Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis","volume":"103","author":"Grzymala-Lubanski","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2025.09.010_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.thromres.2014.02.031","article-title":"Mechanical heart valve prosthesis and warfarin\u2013treatment quality and prognosis","volume":"133","author":"Grzymala-Lubanski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.010_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188482","article-title":"The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis","volume":"12","author":"Vestergaard","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.09.010_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.2004.05348.x","article-title":"Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism","volume":"128","author":"Veeger","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.09.010_bib16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/bcp.13046","article-title":"Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management","volume":"82","author":"Abohelaika","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2025.09.010_bib17","first-page":"263","article-title":"The mechanism of action of oral anticoagulants and its consequences for the practice of oral anticoagulation","volume":"15","author":"Hemker","year":"1985","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2025.09.010_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1160\/TH02-10-0179","article-title":"Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon","volume":"90","author":"Fihn","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2018.04.042","article-title":"Italian Fed. of Anticoagulation Clinics. Mechanical prosthetic heart valves: quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study","volume":"267","author":"Poli","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2025.09.010_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113627","article-title":"Sex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up","volume":"9","author":"Nilsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.09.010_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14064","article-title":"Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk","volume":"75","author":"Pastori","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jtha.2025.09.010_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2007-996422","article-title":"Monitoring therapy with anticoagulants in The Netherlands","volume":"25","author":"Breukink-Engbers","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib24","article-title":"Persoonskenmerken van alle in deGemeentelijke Basis Administratie (GBA) ingeschreven personen,geco\u00f6rdineerd","volume":"V1","year":"2021","journal-title":"ODISSEI Portal"},{"key":"10.1016\/j.jtha.2025.09.010_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jtha.2025.09.010_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/gme.0b013e31818aefef","article-title":"Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies","volume":"16","author":"Dratva","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jtha.2025.09.010_bib27","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2007-2093","article-title":"Relationship of serum antim\u00fcllerian hormone concentration to age at menopause","volume":"93","author":"van Disseldorp","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2025.09.010_bib29","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"Journal of Open Source Software"},{"key":"10.1016\/j.jtha.2025.09.010_bib30","author":"Wickham"},{"key":"10.1016\/j.jtha.2025.09.010_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i03","article-title":"Dates and times made easy with lubridate","volume":"40","author":"Grolemund","year":"2011","journal-title":"J Statistical Software"},{"key":"10.1016\/j.jtha.2025.09.010_bib32","author":"Wickham"},{"key":"10.1016\/j.jtha.2025.09.010_bib33","author":"Wickham"},{"key":"10.1016\/j.jtha.2025.09.010_bib34","first-page":"570","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R Journal"},{"key":"10.1016\/j.jtha.2025.09.010_bib35","author":"Wickham"},{"key":"10.1016\/j.jtha.2025.09.010_bib36","author":"Therneau"},{"key":"10.1016\/j.jtha.2025.09.010_bib37","author":"Stevenson"},{"key":"10.1016\/j.jtha.2025.09.010_bib38","article-title":"tableone: Create 'Table 1' to Describe Baseline Characteristics with or without Propensity Score Weights","author":"Yoshida","year":"2022","journal-title":"R package version 0.13.2"},{"key":"10.1016\/j.jtha.2025.09.010_bib39","author":"Gerds"},{"key":"10.1016\/j.jtha.2025.09.010_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjh.16528","article-title":"Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study","volume":"190","author":"Pastori","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.09.010_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0043-1777827","article-title":"Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin","volume":"124","author":"Johansson","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ejcts\/ezw151","article-title":"Male-female differences and survival in patients undergoing isolated mitral valve surgery: a nationwide cohort study in the Netherlands","volume":"50","author":"Mokhles","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtha.2025.09.010_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000868","article-title":"Male-female differences in aortic valve and combined aortic valve\/coronary surgery: a national cohort study in the Netherlands","volume":"5","author":"Mokhles","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.jtha.2025.09.010_bib44","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jacc.2021.08.081","article-title":"Sex-related factors in valvular heart disease: JACC Focus Seminar 5\/7","volume":"79","author":"Hahn","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.09.010_bib45","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1093\/eurheartj\/ehae523","article-title":"Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey","volume":"45","author":"Mascherbauer","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.09.010_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.121.319914","article-title":"Sex differences and similarities in valvular heart disease","volume":"130","author":"DesJardin","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2025.09.010_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ehjqcco\/qcad018","article-title":"Alerting trends in epidemiology for calcific aortic valve disease, 1990-2019: an age-period-cohort analysis for the Global Burden of Disease Study 2019","volume":"9","author":"Shu","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jtha.2025.09.010_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13374","article-title":"Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management","volume":"50","author":"Mutagaywa","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jtha.2025.09.010_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jtcvs.2019.02.061","article-title":"Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis","volume":"159","author":"Havers-Borgersen","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2025.09.010_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.athoracsur.2003.12.058","article-title":"Late incidence and determinants of stroke after aortic and mitral valve replacement","volume":"78","author":"Ruel","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.09.010_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1160\/TH11-07-0481","article-title":"Haemostatic variables during normal menstrual cycle. A systematic review","volume":"107","author":"Knol","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib52","first-page":"588","article-title":"Plasma levels of activated factor VII decrease during the menstrual cycle","volume":"80","author":"Kapiotis","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1538-7836.2007.02401.x","article-title":"ISTH SSC Subcommittee on Women's Health Issues. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy","volume":"5","author":"Blomb\u00e4ck","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0038-1646528","article-title":"A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters","volume":"61","author":"Lindberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib55","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(83)91562-3","article-title":"Menopausal status and haemostatic variables","volume":"1","author":"Meade","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.09.010_bib57","article-title":"Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III","author":"van der Zande","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.09.010_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC)","volume":"132","author":"van Hagen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.09.010_bib59","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/1471-0528.14478","article-title":"Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system","volume":"124","author":"Vause","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2025.09.010_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/tera.10054","article-title":"Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis","volume":"66","author":"van Driel","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.jtha.2025.09.010_bib61","series-title":"Eur Heart J","first-page":"ehaf193","article-title":"2025 ESC Guidelines for the management of cardiovascular disease and pregnancy","author":"De Backer","year":"2025"},{"key":"10.1016\/j.jtha.2025.09.010_bib62","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.1016\/S2352-3026(24)00313-2","article-title":"Time trends in antithrombotic therapy during pregnancy and maternal and perinatal outcomes in the Netherlands (2013\u201319): a nationwide cohort study","volume":"11","author":"Chen","year":"2024","journal-title":"Lancet Haematology"},{"key":"10.1016\/j.jtha.2025.09.010_bib63","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.09.010_bib64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/hrt.2008.146688","article-title":"Gender differences in the long-term outcomes after valve replacement surgery","volume":"95","author":"Kulik","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2025.09.010_bib65","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.athoracsur.2005.11.052","article-title":"Sex-specific long-term outcomes after combined valve and coronary artery surgery","volume":"81","author":"Doenst","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.09.010_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013260","article-title":"Sex differences in long-term survival after major cardiac surgery: a population-based cohort study","volume":"8","author":"Johnston","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.09.010_bib67","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.jvca.2019.10.011","article-title":"Sex differences in long-term outcomes after surgical aortic valve replacement: a nationwide propensity-matched study","volume":"34","author":"Myllykangas","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.09.010_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2015.04.034","article-title":"Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands","volume":"136","author":"Zhang","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.010_bib69","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1365-2141.2002.03493.x","article-title":"Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon","volume":"117","author":"Gadisseur","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.09.010_bib70","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"de Jong","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.010_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100072","article-title":"How do anticoagulants impact menstrual bleeding and quality of life?\u2014the PERIOD study","volume":"7","author":"Patel","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.010_bib72","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2010.12.011","article-title":"Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation","volume":"84","author":"Huq","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2025.09.010_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102712","article-title":"Comparative effectiveness of warfarin management strategies: a systematic review and network meta-analysis","volume":"74","author":"Dhippayom","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtha.2025.09.010_bib74","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2018.03.535","article-title":"Anticoagulation and antiplatelet strategies after On-X mechanical aortic valve replacement","volume":"71","author":"Puskas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.09.010_bib75","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1182\/bloodadvances.2019000067","article-title":"A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation","volume":"3","author":"Paquette","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/j.jtha.2025.09.010_bib76","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2021.02.025","article-title":"American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group. Contraception and reproductive planning for women with cardiovascular disease: JACC focus seminar 5\/5","volume":"77","author":"Lindley","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.09.010_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.041885","article-title":"For American College of Cardiology Cardiovascular Disease in Women Committee. What every cardiologist should know about contraception and reproductive planning in 2025","volume":"14","author":"Cho","year":"2025","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:04:55Z","timestamp":1781453095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625006002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538783625006002"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.010","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}